SRT 2183

CAS : 1001908-89-9

Ref. 3D-BQB90889

Informations sur le produit

• Nom: SRT 2183
• CAS: 1001908-89-9

Description

SRT 2183 is an experimental drug that has been shown to have anti-cancer properties. It blocks the transcription of a number of genes that are involved in oxidative injury, cell growth, and inflammation. SRT 2183 activates AMPK by binding to the regulatory subunit known as alpha2. This activation leads to increased autophagy and apoptosis in cancer cells. The drug also works by blocking the production of certain proteins that are involved in metabolic disorders, such as type-2 diabetes mellitus and obesity. SRT 2183 has been shown to be safe for use in clinical trials with people who have cancer or metabolic disorders.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 468.57 g/mol
• Formule: C₂₇H₂₄N₄O₂S
• Degré de pureté: Min. 95%